People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Pharmaceuticals, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eikonoklastes Therapeutics, Inc. | — | Pharmaceuticals | Series A | $25.0M | $43.9M | 2021 |
| Owlstone Inc. | — | Other | Seed | $9.4M | $5.5M | 2011 |
| LeggUP Inc. | — | Other Technology | Pre-Seed | $750K | $31.8M | 2019 |
Thomas Finn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Finn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Brennan | 1 | 12 |
| Robert Johnson | 1 | 9 |
| Joseph Nolan | 1 | 5 |
| Samuel Lee | 1 | 4 |
| Yiannis Monovoukas | 1 | 3 |
| Neel Patel | 1 | 2 |
| THOMAS P FINN | 1 | 2 |
| Bret Bader | 1 | 2 |
| YIANNIS SHEPARD MONOVOUKAS | 1 | 1 |
| Bruce Halpryn | 1 | 1 |
| Kenneth Morand | 1 | 1 |
| Meyer Frucher | 1 | 1 |
| BRET I BADER | 1 | 1 |
| VIKTOR BULLAIN | 1 | 1 |
| Ashley Boone | 1 | 1 |
| WILLIAM GALTNEY JR | 1 | 1 |
| David Ruiz-Alonso | 1 | 1 |
| Andrew Koehl | 1 | 1 |
| Paul Boyle | 1 | 1 |
| H SHEPARD BOONE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.